Tagged Articles

deadly 116 articles

Generic Yaz will include same blood clot warnings

Watson Pharmaceuticals has launched Vestura, a generic version of Bayer’s blockbuster birth control pill Yaz. Like their brand-name counterpart, these pills will also carry a safety announcement on their packaging, warning users that studies suggest the drospirenone-containing pills may put users at greater risk for developing life threatening blood clots. Yaz, as well as the brands Yasmin, Beyaz, Safyral, and other generic varieties, combine the hormones drospirenone and ethinyl estradiol. Yaz and its generic versions had sales of about $510 million last year alone. Watson hopes to take a bite out of those profits. However, just as Watson was vying ... Read More

Long flights, birth control pills increase blood clot risk

Flying coach instead of first-class does not increase your chances of developing blood clots, according to new guidelines from the American College of Chest Physicians. But flying with risk factors may increase your chance of getting the potentially deadly condition. People who fly are warned that sitting in one place for too long without walking around and stretching their legs can make them more susceptible to blood clots, a situation that has been nicknamed “economy class syndrome.” The idea is that roomier first-class seats offer more space for frequent movement and are safer, but the new guidelines put that myth to ... Read More

FDA panel member ‘well utilized’ by Yaz maker

A Food and Drug Administration (FDA) panel member who voted to keep the birth control pills Yaz and Yasmin on the market despite studies that showed the pills put women at greater risk for deadly blood clots was praised by the drugs’ maker Bayer in a 2008 report saying, “She will be well utilized.” The adviser, Paula Hillard, M.D., with Stanford’s School of Medicine, is listed on the medical school’s website as a paid consultant receiving $5,000 or more annually from a division of Bayer. Hillard’s apparent conflict of interest on the federal agency panel was noted by former FDA ... Read More

FDA rejects type 2 diabetes drug based on bladder, breast cancer risks

The Food and Drug Administration (FDA) has rejected the experimental type 2 diabetes drug Dapagliflozin because it poses a risk for bladder and breast cancers. Drug makers Bristol-Myers Squibb and AstraZeneca must provide more data on the drug’s risks and benefits before the FDA would be willing to consider approving the drug for use in the United States. Dapagliflozin works by increasing renal glucose elimination, thereby allowing more sugar to be excreted in the urine. An FDA advisory panel voted in July to recommend the approval for the drug, but raised concerns over the cancer risks that rose out of ... Read More

Watchdog group pushes FDA panel to revote on Yaz safety

A consumer watchdog group is calling for a revote by a Food and Drug Administration (FDA) advisory panel, after discovering that some members of the panel had ties to drug companies that made the pills under review. The FDA panel was charged with reviewing studies that showed a newer generation of birth control pills containing the hormone drospirenone put women at greater risk for life threatening blood clots than other oral contraceptives with other hormones. Drospirenone-containing pills include Yaz and Yasmin, made by Bayer. The drug company also sells versions of the pills containing folic acid under the brand names ... Read More

Paula Deen promotes diabetes drug with possible thyroid cancer risk

Paula Deen, the celebrity chef who has built a career on fried and fattening Southern foods, announced this week on NBC’s Today show that she has been living with type 2 diabetes for three years, and that she has come public with her diagnosis to help promote a new diabetes drug. Deen, who will turn 65 on Thursday, is now a spokesperson for Novo Nordisk, and is promoting the drug company’s online program, Diabetes in a New Light. She admits she is taking the company’s once-daily noninsulin injection, Victoza. Considered a first line defense for people with type 2 diabetes, ... Read More

Pros and cons of birth control pills for nuns

For centuries, nuns have been at greater risk for developing breast, ovarian and uterine cancers – diseases that are more common in women who do not have children. But a new study published in The Lancet suggests nuns could greatly reduce their risk of these deadly cancers if they started taking birth control pills. By taking a vow of celibacy, nuns deny themselves pregnancy and lactation, which means they have more menstrual cycles. Statistically, women who have more periods tend to be at greater risk for breast, ovarian and uterine cancers. Comparatively, women who have babies beginning at a young ... Read More

Why would FDA panel not ban Yaz over blood clot risk?

Why did an advisory panel of experts for the Food and Drug Administration (FDA) not vote to ban the popular birth control pill Yaz and other pills of its generation containing the hormone drospirenone, instead opting to recommend that the pills carry a stronger warning for life-threatening blood clots? There is no doubt that with all oral contraceptives there is a slight risk for blood clots. Bayer, maker of Yaz and a family of other drospirenone-containing pills such as Yasmin, Beyaz and Safyral, has consistently claimed its pills were no more as dangerous than other birth control pills. However, newer ... Read More

FDA issues death-risk warning on heart drug

Multaq (dronedarone), a drug used to treat arrhythmias, can cause death or serious cardiovascular events if taken by patents in permanent atrial fibrillation, the Food and Drug Administration (FDA) warns. Multaq is used for a different but related condition. It is designed to reduce the risk of hospitalization in patients with paroxysmal or persistent atrial fibrillation or atrial flutter, with a recent episode of either of these conditions and associated cardiovascular risk factors, who are in sinus rhythm or who will be cardioverted. The initial approval of Multaq for these conditions was based on data that showed use of the ... Read More

New studies show increased risk of blood clots with Yaz

A new study backs up concerns of previous studies that show birth control pills containing the hormone drospirenone, such as Yaz and Yasmin, are more likely to cause deadly blood clots than oral contraceptives made with older generation hormones. The study, released last month, puts the blood clot risk with drospirenone-containing pills at 43 to 65 percent greater when compared to pills with other types of hormones. The latest study is based on data from 330,000 Israeli women. Previous research, involving 835,826 women ranging in age from 10 to 55 who were taking pills like Yaz, suggested the blood clot ... Read More